Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 32,387 articles published since 2008
|||| 50 

These are the 32387 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
301 Editorial Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies? 2014

Zheng, Lei. ·Departments of Oncology & Surgery, The Sidney Kimmel Cancer Center, & the Skip Viragh Center for Pancreatic Cancer Research & Clinical Care, Johns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 488, Baltimore, MD 21231, USA. ·Immunotherapy · Pubmed #25428641.

ABSTRACT: -- No abstract --

302 Editorial [The diagnosis and treatment for pancreatic cancer: current status and future directions]. 2014

Zhao, Yupei. ·Email: zhao8028@263.net. ·Zhonghua Wai Ke Za Zhi · Pubmed #25410774.

ABSTRACT: -- No abstract --

303 Editorial Targeting IL-17 for pancreatic cancer prevention. 2014

McAllister, Florencia / Leach, Steven D. ·Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX. · The David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY. ·Oncotarget · Pubmed #25393980.

ABSTRACT: -- No abstract --

304 Editorial Intraductal papillary mucinous neoplasms of the pancreas. 2014

Tanaka, Masao. ·From the Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ·Pancreas · Pubmed #25333396.

ABSTRACT: -- No abstract --

305 Editorial Snapshots April-August 2014. 2014

Anonymous2430808. · ·Pancreatology · Pubmed #25278301.

ABSTRACT: -- No abstract --

306 Editorial [Coffee and the pancreas: a half life of medical truth]. 2014

Frossard, Jean-Louis / Moradpour, Darius. · ·Rev Med Suisse · Pubmed #25276994.

ABSTRACT: -- No abstract --

307 Editorial Insights into the role of nicotine in pancreatic stem cell activation and acinar dedifferentiation. 2014

Ponnusamy, Moorthy P / Batra, Surinder K. ·Department of Biochemistry and Molecular Biology, Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska. · Department of Biochemistry and Molecular Biology, Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: sbatra@unmc.edu. ·Gastroenterology · Pubmed #25265575.

ABSTRACT: -- No abstract --

308 Editorial Volume-outcome in cancer surgery: why has the data not affected policy change? 2014

Evans, Douglas B / Tsai, Susan. ·Pancreatic Cancer Program, Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA, devans@mcw.edu. ·Ann Surg Oncol · Pubmed #25239003.

ABSTRACT: -- No abstract --

309 Editorial Comment on Han L et al.: prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. 2014

Li, Chenggang / Zhao, Zhiming / Liu, Rong. ·Department of Surgical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, People's Republic of China, lcgang301@sohu.com. ·Tumour Biol · Pubmed #25172098.

ABSTRACT: -- No abstract --

310 Editorial The increasing diversity of KRAS signaling in pancreatic cancer. 2014

Siveke, Jens T. ·II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Electronic address: jens.siveke@lrz.tum.de. ·Gastroenterology · Pubmed #25167989.

ABSTRACT: -- No abstract --

311 Editorial Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected]. 2014

Toriola, Adetunji T / Fields, Ryan C. ·Department of Surgery, Division of Public Health Sciences, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA. ·Future Oncol · Pubmed #25145419.

ABSTRACT: -- No abstract --

312 Editorial Mistletoe treatment for cancer--promising or passé? 2014

Lordick, Florian. ·University Cancer Center Leipzig (UCCL), University of Leipzig. ·Dtsch Arztebl Int · Pubmed #25142074.

ABSTRACT: -- No abstract --

313 Editorial More harm than good? 2014

Gnerlich, Jennifer L / Posner, Mitchell C. ·Department of Surgery, University of Chicago, Chicago, Illinois, USA. ·Ann Surg Oncol · Pubmed #25023543.

ABSTRACT: -- No abstract --

314 Editorial The role of radiotherapy in the management of upper gastrointestinal and hepato-biliary and pancreatic cancers: current status and future directions. 2014

Mukherjee, S / Symonds, R P. ·MRC/CRUK Oxford Institute for Radiation Oncology and Churchill Hospital, Oxford, UK. Electronic address: Somnath.mukherjee@oncology.ox.ac.uk. · Department of Cancer Studies & Molecular Medicine, University of Leicester, Leicester Royal Infirmary, Leicester, UK. ·Clin Oncol (R Coll Radiol) · Pubmed #24996376.

ABSTRACT: -- No abstract --

315 Editorial Cellular and molecular conspirators in pancreas cancer. 2014

Hingorani, Sunil R. ·Clinical Research Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA and Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA 98195, USA srh@fhcrc.org. ·Carcinogenesis · Pubmed #24987024.

ABSTRACT: -- No abstract --

316 Editorial [Editorial]. 2014

Ghadimi, Michael. · ·Zentralbl Chir · Pubmed #24967997.

ABSTRACT: -- No abstract --

317 Editorial Liver and pancreatic cancer related to hepatitis B exposure: has the jury reached a verdict? 2014

Jakab, S Simona. ·Department of Medicine, Section of Digestive Diseases, Yale New Haven Hospital Transplant Center, Yale University, New Haven, CT. ·J Clin Gastroenterol · Pubmed #24921214.

ABSTRACT: -- No abstract --

318 Editorial Diagnosis of pancreatic cancer by contrast-harmonic endoscopic ultrasound (EUS): complementary and not competitive with EUS-guided fine-needle aspiration. 2014

Fusaroli, Pietro / Eloubeidi, Mohamad A. ·American University of Beirut Medical Center, Beirut, Lebanon. ·Endoscopy · Pubmed #24740402.

ABSTRACT: -- No abstract --

319 Editorial [Diagnosis and treatment of pancreatic cystic neoplasms]. 2014

Wang, Chengfeng. ·Email:wangcf369@medmail.com. ·Zhonghua Yi Xue Za Zhi · Pubmed #24721343.

ABSTRACT: -- No abstract --

320 Editorial How to follow up and when to operate asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1? 2014

Tonelli, Francesco. ·Department of Surgery and Translational Medicine, University of Florence, Firenze, Italy. ·J Clin Gastroenterol · Pubmed #24714102.

ABSTRACT: -- No abstract --

321 Editorial Can we move towards personalised pancreatic cancer therapy? 2014

Jamieson, Nigel Balfour / Chang, David K / Grimmond, Sean M / Biankin, Andrew V. ·Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK. ·Expert Rev Gastroenterol Hepatol · Pubmed #24702631.

ABSTRACT: -- No abstract --

322 Editorial Arterial resection for pancreatic cancer: a modern surgeon should change its behavior according to the new therapeutic options. 2014

Vincente, E / Quijano, Y / Ielpo, B. · ·G Chir · Pubmed #24690335.

ABSTRACT: -- No abstract --

323 Editorial Pancreatic cancer: current standards, working towards a new therapeutic approach. 2014

Olowokure, Olugbenga / Qi, Xiaoyang. ·University of Cincinnati - Hematology-Oncology, Internal Medicine, The Vontz Center for Molecular Studies 3125 Eden Avenue, Cincinnati, OH 45267-0508, USA. ·Expert Rev Anticancer Ther · Pubmed #24621210.

ABSTRACT: Pancreatic cancer is the fourth leading cause of cancer deaths with a 5-year survival of 4-6%. Clinical challenges remain to be addressed, since few promising approaches to treat pancreatic cancer have been reported. Here we discuss the potential of a new biotherapeutic agent composed of a lysosomal protein (Saposin C, SapC) and an acidic phospholipid (dioleoylphosphatidylserine, DOPS) which can be assembled into stable nanovesicles (SapC-DOPS) for tackling pancreatic cancer. Phosphatidylserine (PS) is a lipid biomarker on membrane surface of pancreatic cancer cells and can be effectively targeted by SapC-DOPS nanovesicles for cancer-selective therapy. SapC-DOPS nanovesicles have shown excellent pre-clinical therapeutic and safety profiles. Safety profiles which suggests that this new approach is potentially a viable option for pancreatic cancer therapy that is worthy of further clinical development.

324 Editorial Pancreatic diseases. 2014

Schöfl, Rainer. ·4. Interne Abteilung für Gastroenterologie & Hepatologie, Stoffwechsel- & Ernährungsmedizin, Endokrinologie, Krankenhaus der Elisabethinen Linz, Fadingerstraße 1, 4020, Linz, Austria, rainer.schoefl@elisabethinen.or.at. ·Wien Med Wochenschr · Pubmed #24619470.

ABSTRACT: -- No abstract --

325 Editorial Pancreatic cancer in 2014. 2014

Kaltsas, Serafim / Syrigos, Konstantinos N / Saif, Muhammad Wasif. ·University of Athens School of Medicine. Athens Greece. wsaif@tuftsmedicalcenter.org. ·JOP · Pubmed #24618423.

ABSTRACT: -- No abstract --

Back · Next